Updated TAR Criteria for Breast Cancer Gene Analysis

Effective for dates of service on or after December 1, 2017, Treatment Authorization Request (TAR) criteria have been updated for CPT codes 81211 (BRCA1, BRCA2 gene analysis; full sequence analysis and common duplication/deletion variants in BRCA1), 81213 (…uncommon duplication/deletion variants) and 81162 (…full sequence analysis and full duplication/deletion analysis). The once-in-a-lifetime frequency limitation can be overridden with a TAR that meets certain requirements.